HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sreenath V Sharma Selected Research

Oncogene Addiction

3/2012Systematic identification of genomic markers of drug sensitivity in cancer cells.
2/2009ErbBs in lung cancer.
12/2007Oncogene addiction: setting the stage for molecularly targeted cancer therapy.
3/2007Epidermal growth factor receptor mutations in lung cancer.
7/2006"Oncogenic shock": explaining oncogene addiction through differential signal attenuation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sreenath V Sharma Research Topics

Disease

21Neoplasms (Cancer)
11/2015 - 10/2003
6Lung Neoplasms (Lung Cancer)
01/2010 - 05/2005
5Oncogene Addiction
03/2012 - 07/2006
4Shock
09/2010 - 07/2006
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2015 - 12/2005
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2010 - 05/2009
2Carcinogenesis
01/2010 - 01/2008
1Ewing Sarcoma (Sarcoma, Ewing)
03/2012
1Chromosomal Instability (Chromosome Stability)
01/2010
1Rhabdomyosarcoma
05/2009
1Adenocarcinoma
05/2009
1Sarcoma (Soft Tissue Sarcoma)
05/2009
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
05/2009
1Melanoma (Melanoma, Malignant)
06/2008
1Breast Neoplasms (Breast Cancer)
10/2003

Drug/Important Bio-Agent (IBA)

11Phosphotransferases (Kinase)IBA
09/2010 - 05/2005
9Pharmaceutical PreparationsIBA
03/2012 - 07/2006
5Tyrosine Kinase InhibitorsIBA
11/2015 - 05/2005
4Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2015 - 05/2005
4ErbB Receptors (EGF Receptor)IBA
11/2015 - 05/2005
4Proteins (Proteins, Gene)FDA Link
06/2011 - 10/2003
2Gefitinib (Iressa)FDA Link
11/2015 - 05/2005
2Biomarkers (Surrogate Marker)IBA
03/2012 - 04/2010
1Small Interfering RNA (siRNA)IBA
11/2015
1Casein Kinase I (Casein Kinase 1)IBA
11/2015
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
03/2012
1Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2012
1Imatinib Mesylate (Gleevec)FDA Link
09/2010
1ChromatinIBA
04/2010
1Tyrosine (L-Tyrosine)FDA Link
03/2010
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
03/2010
1Cyclin D1IBA
01/2010
1taxaneIBA
01/2010
1Taxoids (Taxanes)IBA
01/2010
1CyclinsIBA
01/2010
1RoscovitineIBA
01/2010
1Cyclin EIBA
01/2010
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2010
1Sunitinib (Sutent)FDA Link
05/2009
1LigandsIBA
05/2009
1Platelet-Derived Growth FactorIBA
05/2009
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
05/2009
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2009
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
05/2009
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2008
1Cisplatin (Platino)FDA LinkGeneric
11/2008
1raf KinasesIBA
06/2008
1geldanamycinIBA
06/2008
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2008
1Proto-Oncogene Proteins B-rafIBA
06/2008
1MitogensIBA
06/2008
1Therapeutic UsesIBA
12/2006
1Oncogene Proteins (Oncogene Protein)IBA
07/2006
1neratinibIBA
05/2005
1belactosin AIBA
01/2004
1monorden (radicicol)IBA
10/2003
1OximesIBA
10/2003

Therapy/Procedure

10Therapeutics
03/2012 - 07/2006
1Chemoprevention
01/2010
1Drug Therapy (Chemotherapy)
02/2009